Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

First clinical experiences reported with S-1197 and its orally active prodrugs

March 22, 1999

Preliminary InTIME-II results point to equivalence of lanoteplase and alteplase in AMI

March 19, 1999

Novel platelet aggregation inhibitors developed by Chinese research team

March 18, 1999

Platelet P2T antagonists patented by Astra, useful as antithrombotics

March 17, 1999

rPSGL-Ig: novel P-selectin antagonist from Genetics Institute as adjunct to thrombolytic therapy

March 16, 1999

Eptifibatide lowers MI incidence, heart muscle injury in ACS patients

March 15, 1999

Genentech reports results on TNK-tPA from TIMI 10B and ASSENT 1 at ACC meeting

March 12, 1999

Heterocyclic factor Xa inhibitors disclosed by Zeneca

March 11, 1999

Results of phase II FROST study of lefradafiban presented at ACC

March 11, 1999

Astra presents results of first human trial of AR-C69931MX at ACC meeting

March 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...